
A new drive-through site for COVID vaccines, tests and infusions is planned at the USA JagTran facility in west Mobile starting next week.

More than 15,000 children are diagnosed with cancer in the United States each year, creating a critical need for research investments that can lead to more targeted and safer treatments.
USA Health Insider is a weekly newsletter featuring news and insights for employees of USA Health as we fulfill our mission to help people lead longer, better lives. Please submit your story ideas to Carol McPhail at [email protected]
A new drive-through site for COVID vaccines, tests and infusions is planned at the USA JagTran facility in west Mobile starting next week.
USA Health researchers and clinicians are experts in their fields, making them trusted sources on many health-related topics in the news.
USA Health regularly recognizes employees for going above and beyond in caring for patients and providing high quality customer service.
One of Us is a series that provides a glimpse into the working world of USA Health, one employee at a time.
The current COVID-19 surge has depleted donations while also increasing the number of requests for assistance from the Emergency PTO Program.
Chaplain Kim Crawford-Meeks says the department will offer access to support 24 hours a day, seven days a week for those receiving care at USA Health hospitals.
Ahmed Abdalla, M.D., brings a special interest in gastrointestinal malignancies and phase 1 clinical trials to the Mitchell Cancer Institute.
The process will create a more efficient and timely system for providers and ensure that follow-up appointments are scheduled.
Specials for USA and USA Health employees include discounts on scrubs and dermatology treatments. Please be sure to bring your employee badge to doctor visits to receive the discount.
USA Health researchers and clinicians are experts in their fields, making them trusted sources on many health-related topics in the news.
Congratulations to the five faculty and staff members from USA Health who were selected for Mobile Bay Magazine’s current 40 Under 40 listing.
Researchers identified MYB as a target protein of interest in the treatment of certain prostate cancer patients.







